Abstract

Mammary tumors are very common in female dogs and its prognosis varies significantly according to the tumor invasion degree. Myoepithelial layer destruction is considered a differential diagnosis parameter of in situ from invasive lesions in human breast cancer. Aiming to evaluate the immunohistochemical expression of p63, a protein specifically expressed by myoepithelial cells of mammary gland, and its correlation with p53 expression, 10 adenomas and 20 carcinomas with and without metastasis of canine mammary gland were studied. There was no significant difference between adenomas and carcinomas for both proteins staining, however, the percentage and continuity of staining was lower in metastatic carcinomas. There was no correlation between p53 and p63 expression, but the higher values of p53 staining were found in carcinomas, according to previous studies. Results showed that p63 is specifically expressed also in myoepithelial cells of canine mammary gland. However, in order to ensure its use as a prognostic marker in canine mammary tumors, further studies involving a higher number of samples should be conducted.

Highlights

  • Mammary tumors are often diagnosed in bitches and are the most common type of tumors in veterinary routine

  • P63 staining was observed at the nuclei of mammary myoepithelial cells surrounding the alveoli and the staining decreased from benign to malignant tumors (Figure 1)

  • When observed low percentage of p63 staining in breast cancer of women, some authors concluded that the p63 expression may be used as a differential diagnosis parameter between in situ and invasive lesions [7,8]

Read more

Summary

Introduction

Mammary tumors are often diagnosed in bitches and are the most common type of tumors in veterinary routine. Veterinary clinicians and pathologists are frequently requested to provide a prognosis of their patients and metastasis and invasion are biological features of malignant tumors that have direct influence on treatment and prognosis of breast cancer patients [1,2,3]. The TP53 gene is a tumor suppressor gene and the most frequently affected site of genetic alterations in human malignancies. It encodes the p53 protein, that controls the expression of a variety of genes involved in cell cycle regulation [9,10,11]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.